摘要
目的:观察爱普列特治疗老年良性前列腺增生症(BPH)的临床效果及安全性。方法:入选BPH患者43例,口服爱普列特片5 mg,2次/日,共4个月。结果:服药前后国际前列腺症状评分(IPSS)、生活质量评分(QOL)、残余尿量(Ru)、最大尿流率(Qmax)、前列腺体积(PV)、前列腺特异抗原(PSA)的变化差异均有显著性(P＜0．05),4个月时有效率为88．37%。结论:爱普列特是一种治疗BPH安全、有效的药物,值得临床推广应用。
objective： To observe the chinical safety and efficacy of epristeride in the treatment of eld benign prostatic hyperplasia （BPH）.Methods：Forty-threc patients with BPH were given epristeride tablets 5mg po,twice daily for 4 moths.Results：The differences in international prostate symptom score（PSS）,residual urine（RU）,maximum flow rate（Qraax）,prostate volume（PV）,prostate specific antigenfPSA） before and after the treatment were statisticaUy significant （P〈0.05）,the effective rate at the termination of the treatment was 88.37% Conclusion：Epristeride is a safety and Effective drug for the treatment of BPH,which should be clinically popularized.
出处
《现代医药卫生》
2007年第2期174-175,共2页
Journal of Modern Medicine & Health
